Literature DB >> 2446697

Leucocyte sodium pump activity after meals or insulin in normal and obese subjects: cause for increased energetic efficiency in obesity?

L L Ng1, M A Bruce, T D Hockaday.   

Abstract

As cellular sodium pumping is an energy consuming process and differences in the obese may account for their energetic efficiency, leucocyte sodium-22 efflux was studied in obese and normal volunteers both in the fasting state and after a test meal or infusion of glucose and insulin intravenously. The 22Na ouabain sensitive efflux rate constant was significantly higher in obese subjects than normal (mean (1 SD) 2.69 (0.40)/h v 2.35 (0.49)/h). Two hours after a 4.2 MJ (1000 kcal) meal there was an increase in the efflux rate constant from its fasting value in normal weight subjects (2.39 (0.33)/h to 2.71 (0.40)/h) but not in obese subjects (2.65 (0.54)/h to 2.61 (0.58)/h). The rise in ouabain sensitive efflux rates was significantly higher in normal than obese subjects. Both groups showed a rise in intracellular sodium concentrations. The euglycaemic clamp produced similar results. Feeding or infusion of insulin increases sodium pump activity more in normal than obese subjects. This difference may contribute to any defective dietary thermogenesis in obesity, which may lead to energetic efficiency and a tendency to gain weight.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446697      PMCID: PMC1248534          DOI: 10.1136/bmj.295.6610.1369

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  39 in total

1.  Thermic effect of glucose in obese subjects studied by direct and indirect calorimetry.

Authors:  P Pittet; P Chappuis; K Acheson; F De Techtermann; E Jéquier
Journal:  Br J Nutr       Date:  1976-03       Impact factor: 3.718

2.  Changes in the erythrocyte sodium pump with age.

Authors:  G J Naylor; D A Dick; E P Worrall; E G Dick; P Dick; L Boardman
Journal:  Gerontology       Date:  1977       Impact factor: 5.140

3.  Relative importance of specific dynamic action in weight-reduction diets.

Authors:  R B Bradfield; M H Jourdan
Journal:  Lancet       Date:  1973-09-22       Impact factor: 79.321

4.  Sodium and potassium flux rates in normal human leucocytes in an artificial extracellular fluid.

Authors:  P J Hilton; J Patrick
Journal:  Clin Sci       Date:  1973-05       Impact factor: 6.124

5.  Intracellular concentrations of water and of the principal electrolytes determined by analysis of isolated human leucocytes.

Authors:  D N Baron; S A Ahmed
Journal:  Clin Sci       Date:  1969-08       Impact factor: 6.124

6.  The effect of insulin on the transport of sodium and potassium in rat soleus muscle.

Authors:  T Clausen; P G Kohn
Journal:  J Physiol       Date:  1977-02       Impact factor: 5.182

Review 7.  Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis.

Authors:  M P Blaustein
Journal:  Am J Physiol       Date:  1977-05

8.  Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.

Authors:  E Reisin; R Abel; M Modan; D S Silverberg; H E Eliahou; B Modan
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

9.  An integrated view of the metabolic and genetic basis for obesity.

Authors:  W P James; P Trayhurn
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

10.  Microcalorimetric determination of energy expenditure due to active sodium-potassium transport in the soleus muscle and brown adipose tissue of the rat.

Authors:  A Chinet; T Clausen; L Girardier
Journal:  J Physiol       Date:  1977-02       Impact factor: 5.182

View more
  2 in total

1.  Altered stoichiometry of the human leucocyte Na+/H+ antiport with decreasing pH.

Authors:  L L Ng; J Bomford
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

2.  Leucocyte sodium efflux and electrolyte content in insulin treated diabetes.

Authors:  L L Ng; D Simmons; M Harker; T D Hockaday
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.